Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis
Tóm tắt
Từ khóa
Tài liệu tham khảo
ES Ford, 2002, Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey, JAMA, 287, 356, 10.1001/jama.287.3.356
E Bugianesi, 2002, Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma, Gastroenterology, 123, 134, 10.1053/gast.2002.34168
IR Wanless, 1990, Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors, Hepatology, 12, 1106, 10.1002/hep.1840120505
BA Neuschwander-Tetri, 2003, Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference, Hepatology, 37, 1202, 10.1053/jhep.2003.50193
JD Browning, 2004, Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity, Hepatology, 40, 1387, 10.1002/hep.20466
I Liou, 2006, Natural history of nonalcoholic steatohepatitis, J Clin Gastroenterol, 40, S11
F Piccinino, 1986, Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies, J Hepatol, 2, 165, 10.1016/S0168-8278(86)80075-7
V Ratziu, 2005, Sampling variability of liver biopsy in nonalcoholic fatty liver disease, Gastroenterology, 128, 1898, 10.1053/j.gastro.2005.03.084
K Ohtsubo, 2006, Glycosylation in cellular mechanisms of health and disease, Cell, 126, 855, 10.1016/j.cell.2006.08.019
N Callewaert, 2004, Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics, Nat Med, 10, 429, 10.1038/nm1006
K Ito, 2012, LecT-hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients, Hepatology, 56, 1448, 10.1002/hep.25815
E Miyoshi, 2008, Biological function of fucosylation in cancer biology, J Biochem, 143, 725, 10.1093/jb/mvn011
S Hashimoto, 2004, alpha1-acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis, Cancer, 101, 2825, 10.1002/cncr.20713
M Wang, 2009, Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma, Cancer Epidemiol Biomarkers Prev, 18, 1914, 10.1158/1055-9965.EPI-08-0980
N Okuyama, 2006, Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation, Int J Cancer, 118, 2803, 10.1002/ijc.21728
M Nakano, 2008, Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers, Int J Cancer, 122, 2301, 10.1002/ijc.23364
Takeda Y, Shinzaki S, Okudo K, Moriwaki K, Murata K, <etal>et al</etal>.. (2011) Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer. Cancer.
M Narisada, 2008, Identification of an inducible factor secreted by pancreatic cancer cell lines that stimulates the production of fucosylated haptoglobin in hepatoma cells, Biochem Biophys Res Commun, 377, 792, 10.1016/j.bbrc.2008.10.061
T Nakagawa, 2006, Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts, J Biol Chem, 281, 29797, 10.1074/jbc.M605697200
JH Lefkowitch, 2005, Morphology of alcoholic liver disease, Clin Liver Dis, 9, 37, 10.1016/j.cld.2004.11.001
DE Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 41, 1313, 10.1002/hep.20701
EM Brunt, 2010, Histopathology of nonalcoholic fatty liver disease, World J Gastroenterol, 16, 5286, 10.3748/wjg.v16.i42.5286
Y Yoon, 1998, Ethanol-induced alterations of the microtubule cytoskeleton in hepatocytes, Am J Physiol, 274, G757
W Chambers, 1993, Abnormally fucosylated haptoglobin as a marker for alcoholic liver disease but not excessive alcohol consumption or non-alcoholic liver disease, Clin Chim Acta, 219, 177, 10.1016/0009-8981(93)90209-M
AJ Sanyal, 2002, AGA technical review on nonalcoholic fatty liver disease, Gastroenterology, 123, 1705, 10.1053/gast.2002.36572
RK Sterling, 2006, Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection, Hepatology, 43, 1317, 10.1002/hep.21178
AG Shah, 2009, Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease, Clin Gastroenterol Hepatol, 7, 1104, 10.1016/j.cgh.2009.05.033
Y Sumida, 2012, Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population, BMC Gastroenterol, 12, 2, 10.1186/1471-230X-12-2
CA Matteoni, 1999, Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity, Gastroenterology, 116, 1413, 10.1016/S0016-5085(99)70506-8
ZM Younossi, 2011, Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality, Hepatology, 53, 1874, 10.1002/hep.24268
C Lackner, 2011, Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective, Expert Rev Gastroenterol Hepatol, 5, 223, 10.1586/egh.11.8
A Wieckowska, 2006, In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease, Hepatology, 44, 27, 10.1002/hep.21223
AE Feldstein, 2009, Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study, Hepatology, 50, 1072, 10.1002/hep.23050
M Przybylo, 2007, Identification of proteins bearing beta1–6 branched N-glycans in human melanoma cell lines from different progression stages by tandem mass spectrometry analysis, Biochim Biophys Acta, 1770, 1427, 10.1016/j.bbagen.2007.05.006
A Grassadonia, 2004, 90K (Mac-2 BP) and galectins in tumor progression and metastasis, Glycoconj J, 19, 551, 10.1023/B:GLYC.0000014085.00706.d4
M Nonaka, 2011, Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) recognizes a novel ligand, Mac-2-binding protein, characteristically expressed on human colorectal carcinomas, J Biol Chem, 286, 22403, 10.1074/jbc.M110.215301
Nakagawa T, Moriwaki K, Terao N, Miyamoto Y, Kamada Y, <etal>et al</etal>.. (2012) Analysis of Polarized Secretion of Fucosylated Alpha-Fetoprotein in HepG2 Cells. J Proteome Res.
Y Kitagawa, 1994, N-glycosylation of erythropoietin is critical for apical secretion by Madin-Darby canine kidney cells, Exp Cell Res, 213, 449, 10.1006/excr.1994.1222
A Kuno, 2011, Multilectin assay for detecting fibrosis-specific glyco-alteration by means of lectin microarray, Clin Chem, 57, 48, 10.1373/clinchem.2010.151340
ZM Younossi, 1998, Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations, Mod Pathol, 11, 560
S Gawrieh, 2011, Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology, Ann Diagn Pathol, 15, 19, 10.1016/j.anndiagpath.2010.08.001
R Juluri, 2011, Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease, J Clin Gastroenterol, 45, 55, 10.1097/MCG.0b013e3181dd1348